tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLLCF Stock Latest News

Molecular Partners’ Strategic Advancements and Promising Pipeline Drive Buy Rating
RatingsMolecular Partners’ Strategic Advancements and Promising Pipeline Drive Buy Rating
14h ago
MOLN
Molecular Partners’ Promising MP0533 Program Drives Buy Recommendation
PremiumRatings
Molecular Partners’ Promising MP0533 Program Drives Buy Recommendation
5d ago
MOLN
Molecular Partners presents new data on Radio-DARPin, Switch-DARPin programs
PremiumThe Fly
Molecular Partners presents new data on Radio-DARPin, Switch-DARPin programs
24d ago
MOLN
Molecular Partners: Strategic Positioning and Innovative Platforms Drive Buy Rating in Oncology Space
PremiumRatings
Molecular Partners: Strategic Positioning and Innovative Platforms Drive Buy Rating in Oncology Space
2M ago
MOLN
Molecular Partners initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Molecular Partners initiated with an Outperform at LifeSci Capital
2M ago
MOLN
Molecular Partners’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsMolecular Partners’ Earnings Call: Progress Amid Challenges
2M ago
Molecular Partners AG: Strong Financials and Promising Pipeline Justify Buy Rating
Premium
Ratings
Molecular Partners AG: Strong Financials and Promising Pipeline Justify Buy Rating
2M ago
MOLN
Molecular Partners Reports 2024 Earnings and Strategic Progress
Premium
Company Announcements
Molecular Partners Reports 2024 Earnings and Strategic Progress
2M ago
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M
PremiumThe Fly
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M
7M ago
MOLN
Molecular Partners, Orano Med announce presentation of MP0712 data
PremiumThe Fly
Molecular Partners, Orano Med announce presentation of MP0712 data
7M ago
NVS
MOLN
Molecular Partners expands 212Pb co-development agreement with Orano Med
PremiumThe Fly
Molecular Partners expands 212Pb co-development agreement with Orano Med
7M ago
MOLN
Molecular Partners AG (ADR) trading resumes
PremiumThe Fly
Molecular Partners AG (ADR) trading resumes
9M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe FlyMolecular Partners AG (ADR) trading halted, volatility trading pause
9M ago
MOLN
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
Premium
The Fly
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
9M ago
MOLN
Molecular Partners AG (ADR) trading resumes
Premium
The Fly
Molecular Partners AG (ADR) trading resumes
10M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
10M ago
MOLN
Molecular Partners AG (ADR) trading resumes
PremiumThe Fly
Molecular Partners AG (ADR) trading resumes
11M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
11M ago
MOLN
Molecular Partners announces preclinical data from MP0621 trial
PremiumThe Fly
Molecular Partners announces preclinical data from MP0621 trial
11M ago
MOLN
Molecular Partners, Orano Med present MP0712 data at SNMMI
PremiumThe FlyMolecular Partners, Orano Med present MP0712 data at SNMMI
11M ago
MOLN
Molecular Partners presents data from completed Phase 1 trial of MP0317
Premium
The Fly
Molecular Partners presents data from completed Phase 1 trial of MP0317
12M ago
MOLN
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
Premium
The Fly
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
1y ago
MOLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >